CDH1 and prostate adenocarcinoma: Jaggi et al. [16], reported downregulation of E-cadherin in GSC 7–10 prostatic adenocarcinoma compared with GSC ≤ 6 (p = 0.015), suggesting a significant association between decreased E-cadherin and increasing grade.